Traditional MedicareCoverageMedium impact
Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
Medicare/CMS - LCD·Neurosurgery, Orthopedics, Pain Management +1 more·Local Coverage Determination
Effective date
Apr 1, 2026
We identified it
Jul 28, 2026
Summary
Wellpoint Federal (MAC Part A & B) has issued a new Local Coverage Determination (LCD L33569) effective April 1, 2026, establishing coverage policies for Percutaneous Vertebral Augmentation (PVA) procedures in Medicare beneficiaries with osteoporotic vertebral compression fractures. This policy defines medical necessity criteria, documentation requirements, and billing guidelines for this minimally invasive spinal procedure. Billing teams must review coverage criteria and implement any prior authorization or documentation requirements before the effective date.
Action Required
By March 31, 2026: Obtain full policy details from the CMS Medicare Coverage Database (LCD L33569, version 32) to identify specific CPT/HCPCS codes subject to coverage restrictions, prior authorization requirements, and medical necessity documentation standards. Coordinate with Providers and Billing Team to: (1) Determine which vertebral augmentation codes (likely including balloon kyphoplasty and vertebroplasty codes) require prior authorization through Wellpoint Federal; (2) Update billing system rules and encounter forms to enforce any new prior auth workflows; (3) Brief clinical staff on medical necessity documentation requirements (e.g., imaging findings, osteoporosis confirmation, fracture acuity); (4) Establish internal audits to ensure claims compliance. Consequence: Claims submitted without required prior authorization or documentation will be denied by Wellpoint Federal MAC, resulting in payment delays and potential patient balance issues.